(Q41024819)

25 September 2017

title

Protein kinase A inhibitors reverse histamine-mediated regulation of IL-5 secretion (English)

1 reference

25 September 2017

Poluektova LY

1

1 reference

25 September 2017

Khan MM

series ordinal

2

1 reference

25 September 2017

publication date

1 March 1998

1 reference

25 September 2017

1 reference

25 September 2017

volume

39

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

9-19

1 reference

Control of human T-lymphocyte interleukin-2 production by a cAMP-dependent pathway

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

cAMP analog antagonists of cAMP action

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Regulation of interleukin-5 production by interleukin-4, interferon-alpha, transforming growth factor-beta and interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

A novel fluorescein-histamine reagent to quantitate histamine receptor expression on leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Regulation of IL-4 and IL-5 secretion by histamine and PGE2

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Signals and nuclear factors that regulate the expression of interleukin-4 and interleukin-5 genes in helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Interleukin-2 treatment-associated eosinophilia is mediated by interleukin-5 production

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Regulation of IL-4 lymphokine gene expression and cellular proliferation in murine T helper type II cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Histamine blocks interleukin 2 (IL-2) gene expression and regulates IL-2 receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Cytokines. 3. Cytokines in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Immunoregulatory T cells in man. Histamine-induced suppressor T cells are derived from a Leu 2+ (T8+) subpopulation distinct from that which gives rise to cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Histamine increases anti-CD3 induced IL-5 production of TH2-type T cells via histamine H2-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Regulation of expression of the IL-2 and IL-5 genes and the role of proteins related to nuclear factor of activated T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

High Frequency of IL-4–Producing CD4+ Allergen-Specific T Lymphocytes in Atopic Dermatitis Lesional Skin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Interleukin (IL)-4 production by human T cells: differential regulation of IL-4 vs. IL-2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Purification of histamine receptor proteins from detergent-solubilized human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Cross-talk between cellular signalling pathways suggested by phorbol-ester-induced adenylate cyclase phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900093-3

7 January 2021

10.1016/S0162-3109(97)00093-3

Identifiers

DOI

1 reference

25 September 2017

1 reference